RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 11.441
EU - Europa 6.241
AS - Asia 4.844
SA - Sud America 819
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 23.465
Nazione #
US - Stati Uniti d'America 11.137
SG - Singapore 1.635
IT - Italia 1.549
CN - Cina 1.361
DE - Germania 1.173
RU - Federazione Russa 820
HK - Hong Kong 780
BR - Brasile 684
SE - Svezia 613
IE - Irlanda 528
VN - Vietnam 490
UA - Ucraina 346
GB - Regno Unito 337
CA - Canada 236
FI - Finlandia 205
AT - Austria 154
IN - India 135
FR - Francia 113
DK - Danimarca 102
ID - Indonesia 77
PL - Polonia 59
NL - Olanda 55
TR - Turchia 55
AR - Argentina 49
BE - Belgio 49
ES - Italia 49
KR - Corea 47
MX - Messico 45
BD - Bangladesh 43
ZA - Sudafrica 41
JP - Giappone 38
IQ - Iraq 36
EC - Ecuador 30
PK - Pakistan 24
IR - Iran 17
RO - Romania 15
BG - Bulgaria 14
CO - Colombia 14
EU - Europa 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
UZ - Uzbekistan 12
CL - Cile 11
LT - Lituania 10
MA - Marocco 10
PY - Paraguay 10
VE - Venezuela 9
AZ - Azerbaigian 8
TN - Tunisia 8
JO - Giordania 7
AL - Albania 6
CZ - Repubblica Ceca 6
GE - Georgia 6
KE - Kenya 6
UY - Uruguay 6
AU - Australia 5
CX - Isole del Natale 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
PH - Filippine 5
PT - Portogallo 5
SN - Senegal 5
TH - Thailandia 5
ET - Etiopia 4
HN - Honduras 4
IL - Israele 4
NG - Nigeria 4
RS - Serbia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
Totale 23.452
Città #
Ann Arbor 2.122
Singapore 1.050
Ashburn 922
Woodbridge 885
Frankfurt am Main 799
Hong Kong 779
Chandler 734
Fairfield 722
Wilmington 526
Dublin 515
Houston 484
Milan 411
Dallas 353
Jacksonville 336
Dearborn 310
New York 292
Santa Clara 292
Seattle 267
Cambridge 214
Beijing 208
Princeton 198
Munich 151
Los Angeles 150
Nanjing 142
Vienna 138
Ho Chi Minh City 135
Rome 129
Hefei 111
Shanghai 110
Helsinki 102
Moscow 85
Lawrence 80
Buffalo 79
Hanoi 70
Altamura 69
Guangzhou 69
São Paulo 69
The Dalles 69
Toronto 69
Chicago 63
Jakarta 62
Lachine 54
San Diego 48
Dong Ket 46
Nanchang 44
Council Bluffs 42
Brussels 41
Seoul 41
Fremont 39
London 39
Ottawa 39
Boardman 37
Andover 35
Denver 34
Changsha 29
Montreal 29
Shenyang 29
Brooklyn 28
Kraków 27
Tianjin 27
Tokyo 27
Turku 27
Bari 25
Bergamo 25
Falls Church 25
Pune 25
Warsaw 25
Nuremberg 24
Rio de Janeiro 24
Zhengzhou 24
Chennai 23
Columbus 23
Jinan 22
Johannesburg 22
Norwalk 20
Verona 20
Washington 20
Hebei 19
Edmonton 18
Haiphong 18
Phoenix 18
Poplar 18
Stockholm 18
Atlanta 17
Orem 17
Bologna 16
Brasília 16
Turin 16
Belo Horizonte 15
Jiaxing 15
Taizhou 15
Brugherio 14
Da Nang 14
Kent 14
Kiev 14
Kunming 14
Monza 14
Ningbo 14
Salvador 14
Curitiba 13
Totale 15.841
Nome #
Vander Fisiologia 624
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 462
Cardiac and neuronal HCN channelopathies 429
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 413
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 384
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 378
Effect of the ketogenic diet in excitable tissues 372
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 358
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 357
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 352
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 344
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 333
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 331
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 329
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 328
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 317
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 316
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 307
Brugada syndrome genetics is associated with phenotype severity 304
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 296
Interstitial pressure and lung oedema in chronic hypoxia 292
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 280
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 275
SCN4A as modifier gene in patients with myotonic dystrophy type 2 272
Hepcidin regulation in a mouse model of acute hypoxia 271
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 269
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 268
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 266
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 263
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 259
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 255
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 254
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 248
How ketogenic diet may be beneficial in controlling neuronal excitability? 247
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 242
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 241
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 241
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 240
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 239
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 237
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 236
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 232
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 232
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 227
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 227
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 225
Gold Branched Nanoparticles for Cellular Treatments 225
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 219
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 218
HCN1 novel mutations in familiar generalized epilepsy 214
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 213
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 213
Acetylation mediates Cx43 reduction caused by electrical stimulation 209
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 207
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 207
Identification and functional characterisation of a new KCNJ2 mutation 206
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 205
Genetics of Long QT, Brugada, and Other Channelopathies 200
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 200
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 199
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 197
Computer simulation of wild-type and mutant human cardiac Na+ current 196
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 194
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 192
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 190
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 189
The effect of exogenous surfactant on alveolar interdependence 186
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 186
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 185
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 184
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 181
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 178
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 176
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 176
Ion Channel as Target for Drugs 176
T-Type Calcium Channels: A Mixed Blessing 176
Invitro- Invivo fluctuation spectroscopies 174
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 174
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 167
BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death 166
Alterations of the Sialylation Machinery in Brugada Syndrome 166
Cardiac sodium channel diseases 153
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 152
Bio-medical and sensor application of silicon nanoparticles 152
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 150
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 149
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 148
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 147
Fisiologia Medica - Terza Edizione 147
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 145
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 144
Ion channels in the heart 142
Giovanni Alfonso Borelli, Giorgio Baglivi, and the origin of the heartbeat in the seventeenth century 140
Vander Fisiologia 138
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 138
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 138
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 133
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 129
Advances in the preparation of novel functionalized nanoparticles for bioimaging 124
A rabbit model of uremia-induced cardiomyopathy 124
Totale 23.309
Categoria #
all - tutte 78.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.507 0 0 0 0 0 211 254 195 197 226 168 256
2021/20221.589 143 180 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.833 56 64 84 127 232 473 337 52 137 48 27 196
2024/20254.214 225 424 168 284 385 245 228 202 444 611 315 683
2025/20265.137 1.097 502 928 1.223 1.288 99 0 0 0 0 0 0
Totale 24.375